Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310024
Status:
COMPLETED
Last Update Posted:
2013-02-07
First Post:
2006-03-29
Brief Title:
Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage III Multiple Myeloma |
| Refractory Multiple Myeloma |
| Stage I Multiple Myeloma |
| Stage II Multiple Myeloma |
Keywords: